Search results
Moderna scores European victory over Pfizer and BioNTech in mRNA patent battle
Endpoints News· 14 hours agoThe European Patent Office on Thursday handed a win to Moderna in a long-running patent battle with...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 10 hours agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 13 hours agoThe EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 14 hours agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
WSAU Wausau· 16 hours ago(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and ...
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders...
Simply Wall St. via Yahoo Finance· 7 days agoKey Insights BioNTech will host its Annual General Meeting on 17th of May CEO Ugur Sahin's total...
Q1 2024 Autolus Therapeutics PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 hour agoNow on the operational corporate side, obviously, there was a lot of activity leading into this year, which resulted in the early February timeframe in two announcements. The first was the announcement ...
BioNTech (NASDAQ:BNTX) Coverage Initiated by Analysts at Evercore ISI
ETF DAILY NEWS· 3 days agoEvercore ISI assumed coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. TD Cowen boosted their ...
FliRT, a group of COVID-19 variants, accounts for most US cases. How to stay safe
Delaware Online | The News Journal via Yahoo News· 10 hours agoWe anticipate the updated vaccines will be better at fighting currently circulating variants,” the...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 15 hours ago/BioNTech SE. The investment firm, which owns approximately 6.8% of Arbutus, also called for a...
